Information for institutional quotation
ARA 290 (Cibinetide): price, documentation and dispatch in Colombia
ARA 290 (Cibinetide) appears in the Péptidos Colombia technical catalog under immunomodulation, longevity, and cellular metabolism, with a single registered presentation: 10 mg vial, from US$185. Structurally it is an undecapeptide, that is, eleven amino acids, derived from the B helix of erythropoietin. That relationship to erythropoietin is the first thing that sets this reference apart from others in the same category: it is not an isolated molecule with no known relation, but a fragment designed from a specific region of a protein already characterized in the catalog. What follows is documentary: what the name states, what presentation and price are currently in force, how a lot is confirmed through the Janoshik Analytical certificate, and what should be reviewed before approving an institutional quote for research and laboratory work.
Presentations and visible prices
| Presentation | Code | Reference price |
|---|---|---|
| 10mg | RA10 | US$185 |
The price above is the public value per vial. Availability and batch documentation are confirmed before the quotation is accepted.
A fragment derived from erythropoietin, not the full protein
The short name Cibinetide and the code ARA 290 designate the same catalog reference, and it is worth using the full form — ARA 290 (Cibinetide) — in any written request so that purchasing, quote, and receiving all stay tied to the same line item. The published classification describes it as an undecapeptide derived from the B helix of erythropoietin, eleven amino acids taken from a specific structural region of that glycoprotein.
That structural relationship to erythropoietin does not make ARA 290 a substitute for it or a reduced version of it: they are two separate catalog entries, each with its own presentation, code, and price. This page does not extend the classification into a claim about what happens in an organism; it stays within the structural relationship stated in the reference's technical description.
Single presentation: what to state in the quote
The catalog lists a single presentation for this reference: 10 mg vial, with a current listed price from US$185. Since there is no second presentation, an institutional quote does not need to choose between milligram amounts: the starting point is always that vial, and the value shown in this page's commercial block is the one in force at the time of the inquiry, not a fixed figure in this text.
With no second presentation to choose from, the institutional request centers on a single line item: the current price is confirmed in this page's commercial block, without assuming it matches another catalog reference.
What the Janoshik Analytical certificate confirms, and what it does not
The identity and purity of an ARA 290 (Cibinetide) lot are not assumed from the name or from the classification published on this page. They are confirmed by the certificate of analysis (COA) that Janoshik Analytical issues per lot: a high-performance liquid chromatography (HPLC) assay for purity and a mass spectrometry (MS) assay for identity, that is, to confirm that the observed mass corresponds to the stated reference.
The COA is handled on request and subject to documentary availability, and it corresponds to a specific lot, not to the reference in general. This page does not publish its own purity figure, because that number, when it exists, belongs to the certificate of the lot delivered. It also does not state a CAS number, molecular formula, molecular weight, or sequence: if those fields are not in the lot's documentation, they remain pending, not filled in by similarity with another reference.
Physical form, storage, and what to check on receipt
The 10 mg presentation corresponds to a powder vial, not a solution measured by volume; that is what distinguishes its handling from references such as Insulin or LC216, presented in liquid form elsewhere in the same catalog. The site's technical sheet declares storage at 2–8 °C, protected from light, the same condition stated in the technical block of every peptide reference in the catalog, always subject to what the received lot's documentation specifies.
On receipt, the full reference name, the 10 mg presentation, and the lot identifier visible on the vial should be checked against the accepted quote. If the COA was requested, verifying it is a separate step from physical receiving: intake into inventory can be recorded while the documentary review of the certificate is still pending, without mixing the two states.
From quote to payment: what is confirmed, and when
Selecting ARA 290 (Cibinetide) in the catalog does not generate a charge. The institutional workflow first records the request, with the 10 mg presentation and the current price; the commercial confirmation follows, fixing the total, the destination, and the payment method in writing. The shipping cost is calculated separately, with rates for Bogotá and for the rest of the country shown on the site's shipping information, and the delivery time confirmed during that same conversation, not on this page. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.
Before authorizing payment, it is worth checking that the quote received states the full reference name, the 10 mg presentation, the unit price, the shipping cost, and, if requested, the status of the COA. The proof of payment should stay linked to the order code so later reconciliation does not depend on scattered messages.
Where it fits within the immunomodulation and cellular metabolism category
Within the immunomodulation, longevity, and cellular metabolism category, ARA 290 (Cibinetide) shares space with references of very different origin: peptides encoded in mitochondrial DNA, thymosins, and also supplier codes with no declared composition, such as RA260. The difference between ARA 290 and that last group is precisely that its structural classification is documented and appears in the catalog.
Compared with the catalog's own recombinant human erythropoietin — a 165-amino-acid glycoprotein — ARA 290 is a fragment of just eleven residues taken from a specific helix of that protein. That difference in size and origin (full protein versus derived fragment) is the comparison this page can support with what is already documented, without extending it to any other conclusion.
Frequently asked questions about ARA 290 (Cibinetide)
What presentations of ARA 290 (Cibinetide) exist in the catalog?
Just one: 10 mg vial, with a current listed price from US$185. The institutional quote confirms that value at the time of the request.
How is the purity of an ARA 290 lot confirmed?
With the certificate of analysis (COA) that Janoshik Analytical issues per lot, using HPLC for purity and mass spectrometry for identity. It is handled on request and subject to documentary availability; this page does not publish a generic figure.
What is the relationship between ARA 290 (Cibinetide) and erythropoietin?
It is an undecapeptide, that is, eleven amino acids, derived from the B helix of erythropoietin. It is a structurally related fragment, not the full protein and not a substitute for the catalog's EPO entry.
How is this reference stored before shipping?
According to the documentation applicable to the lot. The site's technical sheet states 2–8 °C protected from light for the peptide catalog; that condition should be confirmed against the specific lot's documentation on receipt.
How much does shipping cost, and when is it paid?
Rates for Bogotá and for the rest of the country are shown on the site's shipping information. Payment is coordinated after the quote is confirmed in writing, with the method and total already set. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.